TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20738745

Group type: EXPERIMENTAL
Intervention: Nighttime home monitoring system
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 49
Study: 18260178

Group type: EXPERIMENTAL
Intervention: Vitamin K2 alone (Group K)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Vitamin K2 plus etidronate (Group KE)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Vitamin K2 plus risedronate (Group KR)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 79
Study: 15781540

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2% plus clonidine 2 microg/mL
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ropivacaine 0.2%
Number of subjects: 20
Study: 14519752

Group type: EXPERIMENTAL
Intervention: Screened arm (prostate-specific antigen, digital rectal and transrectal ultrasound examinations)
Number of subjects: 17226

Group type: COMPARATOR
Intervention: Control arm (no screening)
Number of subjects: 17226

Group type: EXPERIMENTAL
Intervention: Screened arm (considering all interval cancers)
Number of subjects: 17226

Group type: EXPERIMENTAL
Intervention: Screened arm (considering only cancers classified as T1A-C or T2A)
Number of subjects: 17226
Study: 11078536

Group type: EXPERIMENTAL
Intervention: Quadriceps tendon (QT) tibial tunnel interference fixation
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: EndoButton femoral fixation
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Quadriceps tendon (QT) tendinous end in femoral bone tunnel
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: EndoButton fixation
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: More than 20 loading cycles
Number of subjects: 10
Study: 8930736

Group type: COMPARATOR
Intervention: Power control of energy output model
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Closed-loop temperature control model with a target electrode temperature of 70 degrees C
Number of subjects: 40
Study: 1343608

Group type: EXPERIMENTAL
Intervention: Immunosuppressive therapy
Number of subjects: 0
Study: 3887349

Group type: EXPERIMENTAL
Intervention: Purified porcine insulins (Actrapid and Monotard)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Purified bovine insulins (Neusulin and Neuphane)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups (bovine and porcine)
Number of subjects: 24
Study: 31853960

Group type: EXPERIMENTAL
Intervention: Lebrikizumab (anti-IL-13 monoclonal antibody)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29703414

Group type: EXPERIMENTAL
Intervention: Lactotripeptide (LTP) ingestion for 8 weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo ingestion for 8 weeks
Number of subjects: 15
Study: 27396428

Group type: EXPERIMENTAL
Intervention: Enamel matrix derivative (EMD)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Enamel matrix derivative (EMD) + platelet-rich fibrin (PRF)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (EMD)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (EMD + PRF)
Number of subjects: 28
Study: 24066715

Group type: EXPERIMENTAL
Intervention: Bisoprolol/hydrochlorothiazide (R)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Amlodipine/valsartan (E)
Number of subjects: 156
Study: 22311411

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) applied at acupoints Baihui (GV20), Sishencong (EX-HN1), Hegu (LI4), Neiguan (PC6), Taichong (LR3), Sanyinjiao (SP6), once every other day for 40 days.
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Psycho-intervention (PI) with cognition-behavior mode implemented every 4 days for 40 days.
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Comprehensive therapy (CT) combining EA and PI for 40 days.
Number of subjects: 112
Study: 20120620

Group type: EXPERIMENTAL
Intervention: Total sleep deprivation
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 23
Study: 18694544

Group type: EXPERIMENTAL
Intervention: budesonide/formoterol pMDI 640/18 microg b.i.d.
Number of subjects: 708

Group type: EXPERIMENTAL
Intervention: budesonide/formoterol pMDI 320/9 microg b.i.d.
Number of subjects: 708

Group type: COMPARATOR
Intervention: budesonide pMDI 640 microg b.i.d.
Number of subjects: 708

Group type: EXPERIMENTAL
Intervention: budesonide/formoterol pMDI 640/18 and 320/9 microg b.i.d.
Number of subjects: 708

Group type: EXPERIMENTAL
Intervention: budesonide/formoterol 640/18 and 320/9 microg b.i.d.
Number of subjects: 708
Study: 16213282

Group type: EXPERIMENTAL
Intervention: Equoral (IVAX, USA)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Neoral (Novartis, USA)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Equoral and Neoral
Number of subjects: 70
Study: 11388028

Group type: EXPERIMENTAL
Intervention: Nutritional intervention, specific details not provided
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemoprevention through nutritional modification, specific details not provided
Number of subjects: 0
Study: 9272472

Group type: EXPERIMENTAL
Intervention: Chiropractic management (spinal manipulation, soft tissue therapy, passive stretching for 4 weeks)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Chiropractic management withheld for 4 weeks (control group)
Number of subjects: 21
Study: 7944920

Group type: EXPERIMENTAL
Intervention: TENS at 99Hz over the common peroneal nerve (CPN) for 30 minutes
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: TENS at 99Hz over the sural nerve for 30 minutes
Number of subjects: 11

Group type: COMPARATOR
Intervention: TENS at 50Hz over the CPN or sural nerve
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control values (Hctrl) measured for 5 minutes prior and 10 minutes after TENS
Number of subjects: 11
Study: 3205676

Group type: EXPERIMENTAL
Intervention: Intravenous cyclophosphamide
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Oral cyclophosphamide (tablets)
Number of subjects: 12
Study: 1972334

Group type: EXPERIMENTAL
Intervention: Enoximone 0.5 mg kg‐1 as a bolus (n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Dobutamine 5 micrograms kg‐1 min‐1
Number of subjects: 20
Study: 902653

Group type: EXPERIMENTAL
Intervention: 2 X 6 min workloads (3 min rest between each bout)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 3 X 4 min workloads (1 1/2 min rest between each bout)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 4 X 3 min workloads (1 min rest between each bout)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Correlation with VO2 max
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Predicted VO2 max from Astrand-Ryhming nomogram
Number of subjects: 9
Study: 31792670

Group type: EXPERIMENTAL
Intervention: TELEmedicine intervention for IBD patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 0
Study: 31189287

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate and benzydamine hydrochloride solution
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Calcium and phosphate solution
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Black mulberry syrup
Number of subjects: 83
Study: 27642057

Group type: EXPERIMENTAL
Intervention: MUFA meal
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: CARB meal
Number of subjects: 54

Group type: COMPARATOR
Intervention: CARB diet
Number of subjects: 54

Group type: COMPARATOR
Intervention: SFA diet
Number of subjects: 54
Study: 26206173

Group type: EXPERIMENTAL
Intervention: Self-perceived food addicts
Number of subjects: 210
Study: 23419226

Group type: EXPERIMENTAL
Intervention: Escitalopram for 13 weeks
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: ATR+ status
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: ATR- status
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: ATR+ subjects
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: ATR- individuals
Number of subjects: 67
Study: 20195844

Group type: EXPERIMENTAL
Intervention: High intensity (80% 1RM), 2 days/week (2HI)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Low intensity (40% 1RM), 2 days/week (2LI)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: High intensity (80% 1RM), 3 days/week (3HI)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Low intensity (40% 1RM), 3 days/week (3LI)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 124
Study: 19439506

Group type: EXPERIMENTAL
Intervention: Treatment with thyroid hormone (TH) including thyroxine and T(3) in prolonged critically ill rabbits
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prolonged critically ill patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rabbit model of prolonged critical illness
Number of subjects: 0
Study: 17574679

Group type: EXPERIMENTAL
Intervention: Endothelial progenitor cells (EPCs) therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 16328638

Group type: EXPERIMENTAL
Intervention: 400 mg of oral celecoxib administered 30 min before surgery
Number of subjects: 695

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 695
Study: 11176439

Group type: EXPERIMENTAL
Intervention: Laser tissue soldering
Number of subjects: 138

Group type: COMPARATOR
Intervention: Conventional suturing
Number of subjects: 138
Study: 9399015

Group type: EXPERIMENTAL
Intervention: Zolmitriptan 2.5 mg
Number of subjects: 2480

Group type: EXPERIMENTAL
Intervention: Zolmitriptan 5 mg
Number of subjects: 2480

Group type: EXPERIMENTAL
Intervention: Zolmitriptan
Number of subjects: 2480
Study: 7950168

Group type: EXPERIMENTAL
Intervention: rHuEPO 150 U/kg s.c. once daily for two consecutive days
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: rHuEPO 150 U/kg i.v. once daily for two consecutive days
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: rHuEPO 300 U/kg s.c. once only
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: rHuEPO 300 U/kg i.v. once only
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Iron supplementation (not specified)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: rHuEPO 300 U/kg body weight (single-shot)
Number of subjects: 95
Study: 2823313

Group type: EXPERIMENTAL
Intervention: LTB4
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: PGE2
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Combination of LTB4 and PGE2
Number of subjects: 10
Study: 29029857

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 46
Study: 28448398

Group type: EXPERIMENTAL
Intervention: 150 μg/kg EREM
Number of subjects: 71

Group type: COMPARATOR
Intervention: 7.5 μg/kg IT morphine
Number of subjects: 71
Study: 25643790

Group type: EXPERIMENTAL
Intervention: rhEPO-b (100,000 iu)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 23758655

Group type: EXPERIMENTAL
Intervention: Primary surgery followed by adjuvant chemotherapy (6 cycles of Epirubicin, cisplatin, 5-fluorouracil)
Number of subjects: 314

Group type: COMPARATOR
Intervention: Perioperative chemotherapy (2x3 cycles of Epirubicin, cisplatin, 5-fluorouracil)
Number of subjects: 314
Study: 21963186

Group type: EXPERIMENTAL
Intervention: Surfactant treatment during spontaneous breathing via a thin catheter
Number of subjects: 220

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 220
Study: 18342224

Group type: EXPERIMENTAL
Intervention: Chronicle (Medtronic Inc., Minneapolis, Minnesota)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Control group (optimal medical therapy without hemodynamic monitoring)
Number of subjects: 274
Study: 17161769

Group type: EXPERIMENTAL
Intervention: Intensive BP control with valsartan (diastolic BP goal 75 mm Hg)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Moderate BP control (diastolic BP 80 to 90 mm Hg with placebo)
Number of subjects: 129
Study: 14563182

Group type: EXPERIMENTAL
Intervention: 13C‐urea‐breath test (UBT)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Enzyme Immunoassay (EIA)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Rapid Urease Test (RUT)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Histology
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Culture
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: 13C‐urea‐breath test (UBT) in elderly patients (>65 years old, n=120)
Number of subjects: 314
Study: 11303053

Group type: EXPERIMENTAL
Intervention: Celecoxib in solution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Celecoxib in capsule
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Celecoxib intragastrically in solution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Celecoxib in humans with high fat meal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Celecoxib in humans
Number of subjects: 0
Study: 9076853

Group type: EXPERIMENTAL
Intervention: Relaxation group (progressive muscle relaxation and modified autogenic training)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Ordinary supportive psychotherapy group
Number of subjects: 3

Group type: COMPARATOR
Intervention: No psychiatric treatment group
Number of subjects: 3
Study: 8195440

Group type: EXPERIMENTAL
Intervention: 0.01% chlorhexidine
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 0.05% chlorhexidine
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 0.1% chlorhexidine
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 0.1% triclosan
Number of subjects: 28

Group type: COMPARATOR
Intervention: minus active control for chlorhexidine
Number of subjects: 28

Group type: COMPARATOR
Intervention: minus active control for triclosan
Number of subjects: 28
Study: 3370132

Group type: EXPERIMENTAL
Intervention: Ambulant during the day (group A; n = 19)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Bed rest (group B; n = 19)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sensory deprivation during the first 4 hours of blood pressure recording (group B)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Bed rest alone (group B)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Night rest (group B)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sensory deprivation (group B)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Ambulant (group A)
Number of subjects: 38
Study: 31847574

Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise plus stretching (once per week for 12 weeks)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Moderate-intensity aerobic exercise (control group)
Number of subjects: 64
Study: 30607000

Group type: EXPERIMENTAL
Intervention: Normothermic machine perfusion (NMP)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Cold preservation (CS)
Number of subjects: 24
Study: 27599913

Group type: EXPERIMENTAL
Intervention: Bilastine 20 mg
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Bilastine 10 mg
Number of subjects: 304

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 304
Study: 25347968

Group type: EXPERIMENTAL
Intervention: Diet with 75.4 g kg(‐1) lipid level
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Diet with 51.4 g kg(‐1) lipid level
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Diet with lipid levels (general finding)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Diet with increasing lipid levels
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Diet with lipid levels
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Lipid-fed groups
Number of subjects: 120
Study: 23541174

Group type: EXPERIMENTAL
Intervention: Two-student model
Number of subjects: 16

Group type: COMPARATOR
Intervention: One-student model
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both models
Number of subjects: 16
Study: 21506352

Group type: EXPERIMENTAL
Intervention: Modern physical techniques (electrosurgical, radiosurgical, argon-plasma dissector)
Number of subjects: 272
Study: 19027013

Group type: EXPERIMENTAL
Intervention: Telbivudine
Number of subjects: 1367
Study: 16960700

Group type: EXPERIMENTAL
Intervention: Naltrexone 50 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 15574087

Group type: EXPERIMENTAL
Intervention: Wingate test (30 seconds)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bosco test (60 seconds)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both tests
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bosco test
Number of subjects: 20
Study: 10917072

Group type: EXPERIMENTAL
Intervention: Class II agents (beta-blockers)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Class I antiarrhythmic agents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: d,l-sotalol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dexsotalol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Calcium antagonists (class IV agents)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implantable defibrillators
Number of subjects: 0
Study: 8807684

Group type: EXPERIMENTAL
Intervention: Day hospital-crisis respite program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inpatient setting
Number of subjects: 0
Study: 1570084

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (500 IU/day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (100 IU/day)
Number of subjects: 100
Study: 3931107

Group type: EXPERIMENTAL
Intervention: 10 mg ritanserin
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: 4 mg lorazepam
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: 5 mg ritanserin
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 31060275

Group type: EXPERIMENTAL
Intervention: Hip-Hop to Health (HH)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Standard Nutrition Education (NE)
Number of subjects: 153
Study: 28511594

Group type: EXPERIMENTAL
Intervention: 7 distal screws of a volar plate
Number of subjects: 10

Group type: COMPARATOR
Intervention: 4 distal screws of a volar plate
Number of subjects: 10
Study: 27543563

Group type: EXPERIMENTAL
Intervention: Nicotine patches (5-week supply)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: No intervention control
Number of subjects: 1000
Study: 24271650

Group type: EXPERIMENTAL
Intervention: HRV-biofeedback
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control sessions
Number of subjects: 48
Study: 22225544

Group type: EXPERIMENTAL
Intervention: Probiotic-enriched artichokes (180 g per day, 2 × 10(10) CFU of Lactobacillus paracasei IMPC 2.1)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Probiotic-enriched artichokes
Number of subjects: 20
Study: 20128566

Group type: EXPERIMENTAL
Intervention: 0.4 mg intravitreal dexamethasone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 0.8 mg intravitreal dexamethasone
Number of subjects: 12
Study: 17585971

Group type: EXPERIMENTAL
Intervention: 150 mg/kg TYR (total 300 mg/kg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Cold exposure
Number of subjects: 19
Study: 15750360

Group type: EXPERIMENTAL
Intervention: Individualized homeopathic single remedy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Homeopathic combination medicine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11876695

Group type: EXPERIMENTAL
Intervention: Lansoprazole, 30 mg once daily
Number of subjects: 74

Group type: COMPARATOR
Intervention: Pantoprazole, 40 mg once daily
Number of subjects: 74
Study: 10198739

Group type: EXPERIMENTAL
Intervention: Dilated cardiomyopathy (DCM)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ischemic heart disease
Number of subjects: 50
Study: 9467524

Group type: EXPERIMENTAL
Intervention: Autologous blood transfusion
Number of subjects: 50

Group type: COMPARATOR
Intervention: Homologous blood transfusion
Number of subjects: 50

Group type: COMPARATOR
Intervention: Homologous blood transfusion (3-4 units)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Autologous blood transfusion (3-4 units)
Number of subjects: 50
Study: 1673233

Group type: EXPERIMENTAL
Intervention: bisoprolol 10 mg o.d.
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: atenolol 100 mg o.d.
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo (during run-in period)
Number of subjects: 12
Study: 6811068

Group type: EXPERIMENTAL
Intervention: Treatment for mild hypertension
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Older subjects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Temperature measurements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rainfall
Number of subjects: 0
Study: 30513251

Group type: EXPERIMENTAL
Intervention: Baseline carriage of N. meningitidis
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Carriage of N. meningitidis at 3 months
Number of subjects: 421

Group type: COMPARATOR
Intervention: Recovery of N. meningitidis on selective agar
Number of subjects: 421
Study: 27189375

Group type: EXPERIMENTAL
Intervention: Group B (with alarm)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Group A (without alarm)
Number of subjects: 20
Study: 27402787

Group type: EXPERIMENTAL
Intervention: Pectoralis muscle sling (S)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 21
Study: 24861837

Group type: EXPERIMENTAL
Intervention: Single-agent chemotherapy with TCM
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 22859063

Group type: EXPERIMENTAL
Intervention: Quetiapine XR (50, 150, or 300 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20394494

Group type: EXPERIMENTAL
Intervention: Cleanser A
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Cleanser B (cleanser A plus triclosan, salicylic acid, and azelaic acid)
Number of subjects: 13
Study: 18612923

Group type: EXPERIMENTAL
Intervention: Etanercept alone
Number of subjects: 25

Group type: COMPARATOR
Intervention: Etanercept in combination with methotrexate (MTX)
Number of subjects: 25
Study: 15802771

Group type: EXPERIMENTAL
Intervention: Active vitamin D or its analogs
Number of subjects: 0
Study: 11847165

Group type: EXPERIMENTAL
Intervention: ACE inhibitor treatment
Number of subjects: 161

Group type: COMPARATOR
Intervention: No ACE inhibitor treatment (Control)
Number of subjects: 161